Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide-based PROTACs: Current Challenges and Future Perspectives
Huidan Wang, Miao Chen, Xiaoyuan Zhang, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 2, pp. 208-222
Closed Access | Times Cited: 14

Showing 14 citing articles:

Leveraging aptamers for targeted protein degradation
Zhihao Yang, Qiuxiang Pang, Jun Zhou, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 776-785
Closed Access | Times Cited: 20
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 9
Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review
Ya-Qi Xiao, Jiao Long, Shuang‐Shuang Zhang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107380-107380
Closed Access | Times Cited: 5
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 3
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
A Modified Tridecapeptide Probe for Imaging Cell Junction
Jingrui Li, Yuhan Wu, Chunyu Liu, et al.
(2024)
Open Access | Times Cited: 1
O-GlcNAcylated RALY Contributes to Hepatocellular Carcinoma Cells Proliferation by Regulating USP22 mRNA Nuclear Export
Shiwei Liu, Qingpeng Lv, Xinyu Mao, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3675-3690
Open Access | Times Cited: 1
How to target membrane proteins for degradation: Bringing GPCRs into the TPD fold
Bogusława Korona, Laura S. Itzhaki
Journal of Biological Chemistry (2024), pp. 107926-107926
Open Access | Times Cited: 1
A Modified Tridecapeptide Probe for Imaging Cell Junction
Jingrui Li, Yuhan Wu, Chunyu Liu, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1003-1003
Open Access
Proteolysis Targeting Chimera (PROTACs): An Attractive Technology in CVD Therapeutics—Opportunities and Challenges
Dhruv Gupta, Nidhi Khedpande, Kalyani Barve
(2024), pp. 347-365
Closed Access
Peptide-Based Drugs: Development and Therapeutic Applications
Akanksha Kanojia, Shekhar Singh, Vishal Rai, et al.
Journal for Research in Applied Sciences and Biotechnology (2024) Vol. 3, Iss. 4, pp. 54-68
Open Access
Therapeutic Peptides in the Treatment of Digestive Inflammation: Current Advances and Future Prospects
Liangliang He, Aijing Li, Ping Yu, et al.
Pharmacological Research (2024), pp. 107461-107461
Open Access
Promising Proteolysis-Targeting Chimera for Mutant p53-R175H
Xiaoxi Zhuang, Yidan Guo, Xianghua Sun, et al.
ACS Omega (2024) Vol. 9, Iss. 45, pp. 45138-45146
Open Access
PTGES3 proteolysis using the liposomal peptide-PROTAC approach
Shiwei Liu, Fukang Yuan, Hui Dong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
Page 1

Scroll to top